Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 2,213 $ 1,769
Accounts receivable, net 1,900 2,150
Inventories, net 8,255 7,971
Investment in marketable securities 34,768 27,929
Prepaid expenses and other current assets 1,102 1,402
Total current assets 48,238 41,221
Property and equipment, net 142 151
Equity method investment 12,980 13,325
Right of use assets 4,344 4,474
Deposits and other assets 288 285
Total assets 65,992 59,456
CURRENT LIABILITIES    
Accounts payable and accrued expenses 13,209 11,498
Operating lease liabilities, current portion 1,079 991
Other current liabilities 1,113 5,748
Revolving line of credit to related parties 600 600
Warrant derivative liabilities 13 38
Notes payable 3,954 3,749
Notes payable to related parties 34 193
Convertible debentures, net of discount, current portion 5,908 7,015
Convertible note payable, net of discount 3,150 2,995
Total current liabilities 29,060 32,827
Operating lease liabilities, less current portion 3,810 3,932
Other long-term liabilities 36,968 33,750
Convertible debentures, net of discount, less current portion 886  
Total liabilities 70,724 70,509
STOCKHOLDERS’ DEFICIT    
Preferred stock — par value $0.001 per share, 15,000,000 shares authorized, none issued or outstanding
Common stock — par value $0.001 per share, 250,000,000 shares authorized, 48,987,189 shares and 48,471,446 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 49 48
Additional paid-in capital 216,157 215,207
Accumulated other comprehensive loss (18) (79)
Accumulated deficit (220,920) (226,229)
Total stockholders’ deficit (4,732) (11,053)
Total liabilities & stockholders’ deficit $ 65,992 $ 59,456